当前位置: X-MOL 学术BJU Int. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening
BJU International ( IF 3.7 ) Pub Date : 2021-07-02 , DOI: 10.1111/bju.15535
Sarah Benafif 1 , Holly Ni Raghallaigh 1 , Eva McGrowder 1 , Edward J Saunders 1 , Mark N Brook 1 , Sibel Saya 1, 2 , Reshma Rageevakumar 1 , Sarah Wakerell 1 , Denzil James 1 , Anthony Chamberlain 1 , Natalie Taylor 3 , Matthew Hogben 3 , Barbara Benton 3 , Lucia D'Mello 3 , Kathryn Myhill 3 , Christos Mikropoulos 4 , Hywel Bowen-Perkins 5 , Imran Rafi 6 , Michelle Ferris 7 , Andre Beattie 8 , Shophia Kuganolipava 9 , Tamsin Sevenoaks 10 , Juliet Bower 11 , Pardeep Kumar 3 , Steven Hazell 3 , Nandita M deSouza 12 , Antonis Antoniou 13 , Elizabeth Bancroft 1, 3 , Zsofia Kote-Jarai 1 , Rosalind Eeles 1, 3
Affiliation  

To assess the feasibility and uptake of a community-based prostate cancer (PCa) screening programme selecting men according to their genetic risk of PCa. To assess the uptake of PCa screening investigations by men invited for screening. The uptake of the pilot study would guide the opening of the larger BARCODE1 study recruiting 5000 men.

中文翻译:


BARCODE1 试点:利用种系单核苷酸多态性进行前列腺癌筛查的可行性研究



旨在评估基于社区的前列腺癌 (PCa) 筛查计划的可行性和采用情况,根据前列腺癌的遗传风险选择男性。旨在评估受邀参加筛查的男性对 PCa 筛查调查的接受情况。试点研究的开展将指导招募 5000 名男性的更大规模的 BARCODE1 研究的开展。
更新日期:2021-07-02
down
wechat
bug